Summary, Q&A and close

4 More presentations in this session

Why are we here?

Professor R. Mehran (New York City, US)

Inflammatory biomarkers: why measure hsCRP as well as LDL?

Doctor P. Ridker (Boston, US)

Targeting inflammation in acute myocardial infarction: what, when, who?

Doctor C. Matter (Zurich, CH)

Inflammation management in ASCVD and AMI: what the clinical guidelines say

Professor F. Andreotti (Rome, IT)